Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $7

Benzinga Newsdesk www.benzinga.com Negative 69.8%

Neg 69.8% Neu 0% Pos 0%

Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and lowers the price target from $23 to $7.